scholarly article | Q13442814 |
P356 | DOI | 10.1590/0074-02760160122 |
P8608 | Fatcat ID | release_6s55jv53sjathey2m2s2xmy5aq |
P932 | PMC publication ID | 5066329 |
P698 | PubMed publication ID | 27706378 |
P2093 | author name string | Maria Esther Salles Nogueira | |
Ana Carla Pereira Latini | |||
Maria Renata Sales Nogueira | |||
P2860 | cites work | The continuing challenges of leprosy | Q24545809 |
Unsolved matters in leprosy: a descriptive review and call for further research | Q26747134 | ||
Inflammatory Mediators of Leprosy Reactional Episodes and Dental Infections: A Systematic Review | Q26785530 | ||
Potential plasma markers of Type 1 and Type 2 leprosy reactions: a preliminary report | Q33454062 | ||
Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2 | Q34195975 | ||
Classification of leprosy according to immunity. A five-group system | Q34242412 | ||
Vascular bed-specific hemostasis: role of endothelium in sepsis pathogenesis | Q34303799 | ||
Endothelium: interface between coagulation and inflammation | Q34633538 | ||
Differential gene expression in thrombomodulin (TM; CD141)(+) and TM(-) dendritic cell subsets | Q34979529 | ||
Angiogenesis and lymphangiogenesis in the spectrum of leprosy and its reactional forms | Q34990214 | ||
Risk factors for leprosy reactions in three endemic countries | Q35140523 | ||
EPCR-dependent PAR2 activation by the blood coagulation initiation complex regulates LPS-triggered interferon responses in mice. | Q35584261 | ||
Longitudinal immune profiles in type 1 leprosy reactions in Bangladesh, Brazil, Ethiopia and Nepal | Q35825015 | ||
Soluble thrombomodulin reduces inflammation and prevents microalbuminuria induced by chronic endothelial activation in transgenic mice | Q35849496 | ||
The role of thrombomodulin lectin-like domain in inflammation | Q35927779 | ||
IL-27 Suppresses Antimicrobial Activity in Human Leprosy | Q36054382 | ||
Spatial and temporal dynamics of the endothelium | Q36126944 | ||
The integrin VLA-4 supports tethering and rolling in flow on VCAM-1. | Q36235481 | ||
Multibacillary leprosy patients with high and persistent serum antibodies to leprosy IDRI diagnostic-1/LID-1: higher susceptibility to develop type 2 reactions. | Q36321464 | ||
The lectin-like domain of thrombomodulin confers protection from neutrophil-mediated tissue damage by suppressing adhesion molecule expression via nuclear factor kappaB and mitogen-activated protein kinase pathways | Q36371054 | ||
Tissue factor expression by myeloid cells contributes to protective immune response against Mycobacterium tuberculosis infection | Q36540595 | ||
Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responses | Q36842908 | ||
Expression of adhesion molecules in leprosy lesions | Q36989208 | ||
Activation of VCAM-1 and its associated molecule CD44 leads to increased malignant potential of breast cancer cells | Q37683976 | ||
Biomarkers of endothelial activation/dysfunction in infectious diseases | Q37713182 | ||
Leprosy susceptibility: genetic variations regulate innate and adaptive immunity, and disease outcome | Q37876414 | ||
Endothelium--role in regulation of coagulation and inflammation | Q37918456 | ||
New insights into pathways that determine the link between infection and thrombosis. | Q38003802 | ||
New insights in the pathogenesis of type 1 and type 2 lepra reaction | Q38157605 | ||
Protective and pathological roles of tissue factor in the heart | Q38272797 | ||
Advances in leprosy immunology and the field application: A gap to bridge | Q38698605 | ||
E-selectin and P-selectin expression in endothelium of leprosy skin lesions | Q39481439 | ||
Leprosy type 1 reaction (formerly reversal reaction). | Q40831216 | ||
Increased Langerhans cell accumulation after mycobacterial stimuli | Q42072317 | ||
Longitudinal immune responses and gene expression profiles in type 1 leprosy reactions | Q42235469 | ||
Effects of human soluble thrombomodulin on experimental glomerulonephritis | Q43889533 | ||
Markers of platelet, endothelial cell and blood coagulation activation in leprosy patients with antiphospholipid antibodies. | Q44099584 | ||
Regulation of thrombomodulin expression in human vascular smooth muscle cells by COX-2-derived prostaglandins | Q45182845 | ||
Serum levels of thrombomodulin, intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin in the acute phase of Plasmodium vivax malaria | Q47844306 | ||
Soluble adhesion molecules in sera of patients with leprosy: levels of soluble intercellular adhesion molecule-1 (sICAM-1) rapidly decrease during multi-drug therapy. | Q51024385 | ||
Increased soluble vascular cell adhesion molecule 1 concentrations in patients with primary or systemic lupus erythematosus-related antiphospholipid syndrome: Correlations with the severity of thrombosis | Q58622036 | ||
The VLA-4/VCAM-1 pathway is involved in lymphocyte adhesion to endothelium in rheumatoid synovium | Q67706705 | ||
Serum thrombomodulin. A novel marker of disease activity in systemic lupus erythematosus | Q72340223 | ||
Cytokines: triggers of clinical thrombotic disease | Q73447476 | ||
Overexpression of vascular endothelial growth factor and its endothelial cell receptor KDR in type 1 leprosy reaction | Q74504043 | ||
Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo | Q77342565 | ||
Circulating levels of tissue factor and proinflammatory cytokines in patients with primary antiphospholipid syndrome or leprosy related antiphospholipid antibodies | Q81486591 | ||
Cyclooxygenase 2 expression in vessels and nerves in reversal reaction leprosy | Q83947257 | ||
P433 | issue | 10 | |
P921 | main subject | leprosy | Q36956 |
endothelium | Q111140 | ||
P304 | page(s) | 635-641 | |
P577 | publication date | 2016-10-03 | |
P1433 | published in | Memórias do Instituto Oswaldo Cruz | Q15760238 |
P1476 | title | The involvement of endothelial mediators in leprosy | |
P478 | volume | 111 |
Search more.